Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06567821 · ClinicalTrials.gov registry record · Phase 2
Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy
A Phase 2 study of Chronic Maxillary Rhinosinusitis, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06567821: Recruiting Phase 2 study of Chronic Maxillary Rhinosinusitis, sponsored by Cedars-Sinai Medical Center.
NCT06567821 is a Phase 2 study of Chronic Maxillary Rhinosinusitis that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06567821, a Phase 2 study of Chronic Maxillary Rhinosinusitis, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to examine the effectiveness of navigation in maxillary sinus balloon dilation for the treatment of chronic maxillary rhinosinusitis.
Primary Outcome
There is a 30% expected improvement of success, in favor of navigation over non-navigation balloon sinuplasty devices.
Conditions Studied
Interventions
- DEVICE RELIEVA SPINPLUS® NAV Balloon Sinusplasty System
Study Locations (1)
California
- Cedars Sinai - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
What NCT06567821 shows while recruiting
NCT06567821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Chronic Maxillary Rhinosinusitis appearing as the primary indexed condition, and to 1 intervention - of which RELIEVA SPINPLUS® NAV Balloon Sinusplasty System is the first listed.
NCT06567821 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06567821 about?
NCT06567821 is a clinical study titled "Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy". The purpose of the research is to examine the effectiveness of navigation in maxillary sinus balloon dilation for the treatment of chronic maxillary rhinosinusitis.
What is the current status of trial NCT06567821?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2024-09-04. Estimated completion is 2027-12-31.
What conditions does trial NCT06567821 study?
This clinical trial studies the following conditions: Chronic Maxillary Rhinosinusitis.
What interventions are being tested in trial NCT06567821?
The interventions under investigation include: RELIEVA SPINPLUS® NAV Balloon Sinusplasty System (DEVICE).
Who is sponsoring clinical trial NCT06567821?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06567821 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06567821's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI